Has Michael Schechter received payments from drug or device companies?

Yes. Drug and device makers reported $71,362 in general payments to Michael Schechter across 87 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Schechter did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Schechter come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Schechter

Pediatric Pulmonology · Richmond, VANPI 1831138130

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $47,266 of the $71,362 with a category attached, or 66.2%. 10 manufacturers reported payments, led by AstraZeneca at 47.0% of the total. Reporting peaked in 2022 at $22,559 and has fallen 69.1% since, to $6,981 in 2025. Among pediatric pulmonology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$71,362in general payments, 2019–2025

Across 87 payments — averaging $820.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$34K
Sanofi Pasteur Inc.$22K
GSK$7K
Vertex$3K
Astrazeneca UK Limited$2K
Regeneron Healthcare Solutions, Inc.$2K
plus $2K from 4 others

$293,212in research payments, 2019–2025

Across 67 payments — averaging $4376.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

GSK$127K
Vertex$114K
AbbVie$40K
Novartis$11K
Mylan Inc.$967

What the payments were for

Consulting fees$47,26666%
Speaking & faculty fees$19,85628%
Travel & lodging$2,2593%
Food & beverage$1,8183%
Education$1630%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	28	$33,531
Sanofi Pasteur Inc.	18	$21,767
GSK	10	$7,484
Vertex	2	$2,700
Astrazeneca UK Limited	1	$2,475
Regeneron Healthcare Solutions, Inc.	4	$1,605
Boston Scientific	21	$1,031
AbbVie	1	$575
Sanofi-aventis U.S. LLC	1	$100
Gilead	1	$96

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$71,362 in reported general payments places this provider in the 95th percentile of 23 pediatric pulmonology providers in Virginia.

See all pediatric pulmonology providers in Virginia →

Other pediatric pulmonology in Richmond

Bruce RubinRichmond$156K
Howard SchmidtRichmond$12K
Dagnachew AssefaRichmond$2K
James LothianRichmond$389
Judith VoynowRichmond$102
Aditi PantRichmond$18
Richard KravitzCharlottesville$12K
Sunil KapoorFairfax$4K
Melody HawkinsFairfax$1K
Pearl YuCharlottesville$1K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →